Latest Biologic Stories
DUBLIN, May 07, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/xc7ll7/china_blood)
Company plans to add more than 30,000L of bioreactor capacity across its three sites COPENHAGEN, Denmark, SEATTLE and BERKELEY, Calif., May 7, 2015 /PRNewswire/ --
-- Appointment Reflects Company's Expanded Clinical and Market Driven Focus -- ROCKVILLE, Md., May 7, 2015 /PRNewswire/ --
WASHINGTON, May 5, 2015 /PRNewswire/ -- A coalition of 11 leading companies involved in the development and manufacturing of biopharmaceuticals and "biosimilar" medicines today announced the
CRANBURY, N.J., May 4, 2015 /PRNewswire/ -- Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing monoclonal antibody (mAb) biosimilars, has completed the
Novel anti-inflammatory mechanism of action controls secretion of IL-23 PORTOLA VALLEY, Calif., May 4, 2015 /PRNewswire/ -- Rogne Bioscience, a privately-held biotechnology
FACIT partners with Ontario researchers to create new company TORONTO, May 4, 2015 /PRNewswire/ - The Fight Against Cancer Innovation Trust (FACIT) and its partners are pleased
PLEASANTON, Calif., May 4, 2015 /PRNewswire/ -- Unchained Labs, a refreshingly new biologic tools company, extends its coming out to this year's PEGS conference and launches the UNit -- the
Scientific Poster to be Presented at PEGS The Essential Protein Engineering Summit in Boston NEW YORK and CAMBRIDGE, Mass., May 4, 2015 /PRNewswire/ -- Immune Pharmaceuticals Inc.
-- Executive Brings Significant Biotech Industry Leadership Experience to Team as Company Enters Next Phase of Development -- ROCKVILLE, Md., May 4, 2015 /PRNewswire/ --
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.